Sadistic Homosexual Pedophilia Treatment with Cyproterone Acetate

Cooper, Alan; Baxter, D.; Wong, Winson; Losztyn, S

doi:10.1177/070674378703200833

Cited by 18 publications

(7 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, low plasma testosterone is not necessarily accompanied by reduced sexual activity (A. J. Cooper, 1987;Freund, 1980). Furthermore, both drugs have unpleasant side effects and are unpalatable for the majority of men.…”

Section: Treatment Programs For Sex Offendersmentioning

confidence: 99%

“…Although the drugs undoubtedly lower testosterone levels (e.g., Bradford & Pawlak, 1993), and there is generally a dose-related reduction in sexual arousal, the relationship between the drugs and arousal (in humans particularly) appears to be far from perfect. In addition, low plasma testosterone is not necessarily accompanied by reduced sexual activity (A. J. Cooper, 1987; Freund, 1980).…”

Section: Treating Mentally Disordered Offendersmentioning

confidence: 99%

See 1 more Smart Citation

The treatment of mentally disordered offenders.

Rice¹,

Harris²

1997

Psychology, Public Policy, and Law

View full text Add to dashboard Cite

However narrowly defined, mentally disordered offenders (MDOs) are heterogeneous in demographics, diagnoses, offense characteristics, risk, and clinical needs. Treatment planning for MDOs should begin with an assessment of risk of future violent behavior in the community and risk of violence toward self or others inside an institution. Purposes of treatment among MDOs include treatments both to reduce risk of future violence and to alleviate the mental disorder. Relevant outcome measures include criminal and violent behavior, psychiatric symptomatology, admission to correctional or psychiatric facility, and quality of life. Clinical problems include aggression and problems of institutional management, criminal propensity, life skills deficits, substance abuse, active psychotic symptoms, social withdrawal, and depression. Because evidence relating them to risk of future violence is highest for the first 4 problems, it is argued that inpatient treatments should especially target them. Whenever risk levels and legal circumstances permit, community treatment is to be preferred. Sex offenders are discussed as a group for whom specialized services are indicated. Relapse prevention and program development evaluation are recommended methods for guiding treatment planning at both individual and system levels. Obstacles to implementation of empirically based treatments are discussed, as are suggestions for overcoming such obstacles. Finally, promising directions for future research are suggested.The term mentally disordered offender encompasses a heterogeneous and poorly defined group. In its narrowest interpretation, the category is a legal one and includes insanity acquittees, persons found guilty but mentally ill, persons found unfit to stand trial, mentally disordered sex offenders, sexual predators, and prisoners transferred to mental health facilities. In a 1978 survey , 7% of all the offenders detained in the United States were officially designated as mentally disordered. Of these, 8% were insanity acquittees, 32% were incompetent to stand trial, 6% were mentally disordered sex offenders, and the majority (54%) were convicted prisoners who had been transferred to mental health facilities. By any definition, the overwhelming majority of mentally disordered offenders are men (e.g., Menzies, Chunn, & Webster, 1992;Steadman & Halfon, 1971). Even in its narrow interpretation, however, this population includes a diverse group with a wide range of treatment needs.Most would concede that the true number of mentally disordered offenders is many times higher than that described above. Studies of the prevalence of mental disorder among incarcerated offenders reveal a surprisingly high prevalence. In one study (Hodgins & Cote, 1990), which used the Diagnostic Interview Schedule (Robins, Helzer, Croughan, & Ratcliff, 1981) to establish diagnoses, only 5% of penitentiary inmates in one Canadian province were found not to have a mental

show abstract

Section: Treatment Programs For Sex Offendersmentioning

confidence: 99%

Section: Treating Mentally Disordered Offendersmentioning

confidence: 99%

The treatment of mentally disordered offenders.

Rice¹,

Harris²

1997

Psychology, Public Policy, and Law

View full text Add to dashboard Cite

show abstract

“…With a few additional reports on the use of other psychiatric medications in terms of pharmacotherapies, the most extensive literature is on the use of antiandrogen medications to treat individuals who have committed sex crimes. Based on the theory that decreasing sexual drive or eliminating the ability to perform sexually will reduce criminal behavior on the part of individuals who have committed a sex offense, various clinicians and researchers have used either medroxy progesterone acetate (MPA) (Cooper, Sandhu, Losztyn, & Cernovsky, 1992;Kiersch, 1990) or cyproterone acetate (CPA) (Bradford & Pawlak, 1987;Cooper, 1987;Cooper & Cernovsky, 1994;Cooper, Cernovsky, & Magnus, 1992;Cooper, Sandhu et al, 1992) to reduce sexual offenses. Most of these publications have been case reports supporting the efficacy of these medications.…”

Section: Introductionmentioning

confidence: 99%

Treatment of Pedophilia with Leuprolide Acetate

Raymond¹,

Robinson²,

Kraft

et al. 2002

Journal of Psychology & Human Sexuality

View full text Add to dashboard Cite

To date, the literature on the treatment of individuals who have committed sexual offenses has focused primarily on psychotherapeutic interventions and the use of antiandrogens. Recently case reports and small series supporting the efficacy of other psychiatric medication, such as serotonin reuptake inhibitors, have been published. Only a few publications have looked at the efficacy of leuprolide acetate, an LH-RH antagonist, in treatment of sex offenders. Leuprolide acetate has advantages

show abstract

“…Their use allows also a reduction in sexually deviant fantasies and behavior but does not modify the direction of sexual interest. There are some theoretical risks to CPA and MPA treatment such as liver dysfunction, weight gain, asthenia, hyperglycemia or gynecomastia (14)(15)(16)(17).…”

mentioning

confidence: 99%

Effect of a long‐lasting gonadotrophin hormone‐releasing hormone agonist in six cases of severe male paraphilia

Thibaut

Cordier

Kuhn

1993

Acta Psychiatr Scand

View full text Add to dashboard Cite

Six men with severe paraphilia had been treated with depot gonadotrophin luteinizing releasing hormone analogue (GnRHa) (triptorelin 3.75 mg per month intramuscularly). In 5 cases, the treatment ended their deviant sexual behavior and markedly decreased their sexual fantasies and activities without further significant side effects than those related to hypoandrogenism. This clinical improvement was parallel to the gradual decrease of plasma testosterone level to castration values within the first month. The beneficial effect of this treatment had been maintained at follow-up varying from 7 months to 3 years. One patient interrupted the treatment at the end of the first year and relapsed within 10 weeks. GnRHa treatment, which leads to reversible castration, may constitute a promising treatment of paraphilic behavior and may favor the possibility of concurrent psychotherapy.

show abstract

Sadistic Homosexual Pedophilia Treatment with Cyproterone Acetate

Cited by 18 publications

References 8 publications

The treatment of mentally disordered offenders.

The treatment of mentally disordered offenders.

Treatment of Pedophilia with Leuprolide Acetate

Effect of a long‐lasting gonadotrophin hormone‐releasing hormone agonist in six cases of severe male paraphilia

Contact Info

Product

Resources

About